The outlook of companies tied to Sildenafil's past presents a intricate investment picture . While the initial success generated substantial profits , generic alternatives have significantly eroded revenue. https://thebookmarkage.com/story21609941/copyright-s-flagship-product-and-big-pharma-a-uncertain-investment